Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy

References

• Vasanthavada M, Tong W, Serajuddin ATM. (2008). Development of solid dispersion for poorly water-soluble drugs. In: Liu R, ed. Water-insoluble drug formulation. Boca Raton: CRC Press, pp. 499–529.
   Google Scholar
• Karanth H, Shenoy VS, Murthy RR. (2006). Industrially feasible alternative approaches in the manufacture of solid dispersions: a technical report. AAPS Pharmscitech, 7:87.
   PubMedGoogle Scholar
• Repka MA, Majumdar S, Kumar Battu S, Srirangam R, Upadhye SB. (2008). Applications of hot-melt extrusion for drug delivery. Expert Opin Drug Deliv, 5:1357–1376.
   PubMed Web of Science ®Google Scholar
• Breitenbach J. (2002). Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm, 54:107–117.
   PubMed Web of Science ®Google Scholar
• Repka MA, Battu SK, Upadhye SB, Thumma S, Crowley MM, Zhang F et al. (2007). Pharmaceutical applications of hot-melt extrusion: Part II. Drug Dev Ind Pharm, 33:1043–1057.
   PubMed Web of Science ®Google Scholar
• Friesen DT, Shanker R, Crew M, Smithey DT, Curatolo WJ, Nightingale JA. (2008). Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. Mol Pharm, 5:1003–1019.
   PubMed Web of Science ®Google Scholar
• Heinz A, Gordon KC, McGoverin CM, Rades T, Strachan CJ. (2009). Understanding the solid-state forms of fenofibrate–a spectroscopic and computational study. Eur J Pharm Biopharm, 71:100–108.
   PubMed Web of Science ®Google Scholar
• Serajuddin AT. (1999). Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci, 88:1058–1066.
   PubMed Web of Science ®Google Scholar
• Saleki-Gerhardt A, Ahlneck C, Zografi G. (1994). Assessment of disorder in crystalline solids. Int J Pharm, 101:237–247.
   Web of Science ®Google Scholar
• Ahlneck C, Zografi G. (1995). The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int J Pharm, 123:265–271.
   Web of Science ®Google Scholar
• Albers J, Alles R, Matthée K, Knop K, Nahrup JS, Kleinebudde P. (2009). Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion. Eur J Pharm Biopharm, 71:387–394.
   PubMed Web of Science ®Google Scholar
• Hulsmann S, Backensfeld T, Bodmeier R. (2001). Stability of extruded 17β-estradiol solid dispersions. Pharma Dev Tech, 6:223–229.
   PubMed Web of Science ®Google Scholar
• Marsac PJ, Konno H, Rumondor ACF, Taylor LS. (2008). Re-crystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly(vinylpyrrolidone) and sorbed water. Pharm Res, 25:647–656.
   PubMed Web of Science ®Google Scholar
• Chokshi RJ, Shah NH, Sandhu HK, Malick AW, Zia H. (2008). Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration. J Pharm Sci, 97:2286–2298.
   PubMed Web of Science ®Google Scholar
• Ghebremeskel AN, Vemavarapu C, Lodaya M. (2006). Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions. Pharm Res, 23:1928–1936.
   PubMed Web of Science ®Google Scholar
• Bhugra C, Pikal MJ. (2008). Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state. J Pharm Sci, 97:1329–1349.
   PubMed Web of Science ®Google Scholar
• Rumondor AC, Marsac PJ, Stanford LA, Taylor LS. (2009). Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. Mol Pharm, 6:1492–1505.
   PubMed Web of Science ®Google Scholar
• Rumondor ACF, Taylor LS. (2010). Effect of hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture. Mol Pharm, 7:477–490.
   PubMed Web of Science ®Google Scholar
• Shah B, Kakumanu VK, Bansal AK. (2006). Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids. J Pharm Sci, 95:1641–1665.
   PubMed Web of Science ®Google Scholar
• Bai SJ, Rani M, Suryanarayanan R, Carpenter JF, Nayar R, Manning MC. (2004). Quantification of glycine crystallinity by near-infrared (NIR) spectroscopy. J Pharm Sci, 93:2439–2447.
   PubMed Web of Science ®Google Scholar
• Findlay WP, Bugay DE. (1998). Utilization of Fourier transform-Raman spectroscopy for the study of pharmaceutical crystal forms. J Pharm Biomed Anal, 16:921–930.
   PubMed Web of Science ®Google Scholar
• Taylor LS, Zografi G. (1998). The quantitative analysis of crystallinity using FT-Raman spectroscopy. Pharm Res, 15:755–761.
   PubMed Web of Science ®Google Scholar
• Yoshioka M, Hancock BC, Zografi G. (1994). Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. J Pharm Sci, 83:1700–1705.
   PubMed Web of Science ®Google Scholar
• Hancock BC, Zografi G. (1997). Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci, 86:1–12.
   PubMed Web of Science ®Google Scholar
• Suryanarayan R. (1995). X-ray powder diffractometry. In: Brittain HG, ed. Physical characterization of pharmaceutical solids. New York: Marcel Dekker, pp. 187–221.
   Google Scholar
• Vitez IM. (2004). Utilization of DSC for pharmaceutical crystal form quantitation. J Therm Anal Calorim, 78:33–45.
   Web of Science ®Google Scholar
• Nagapudi K, Jona J. (2008). Amorphous active pharmaceutical ingredients in preclinical studies: preparation, characterization and formulation. Curr Bioact Compd, 4:213–224.
   Google Scholar
• Cheary RW, Coelho AA. (1992). A fundamental parameters approach to X-ray line-profile fitting. J Appl Crystallogr, 25:109–121.
   Web of Science ®Google Scholar
• Henry RF, Zhang GZ, Gao Y. (2003). Fenofibrate. Acta Cryst, E59:O699–O700.
   Google Scholar
• Dollase WA. (1988). Correction of intensities for preferred orientation in powder diffractometry: application of the March model. J Appl Crystallogr, 21:86–91.
   Google Scholar
• Von Dreele RB. (2008). Rietveld refinement. In: Dinnebier RE, Billinge SJL, eds. Powder Diffraction: Theory and practice. Cambridge: RSC Publishing, pp. 266–279.
   Google Scholar
• Kaiser DL, Watters RL. (2007). Certificate of Analysis; Standard Reference Material 1976, National Institute of Standards, Gaithersburg, MD 20899, USA.
   Google Scholar
• Song J, Ren M, Chen Q, Wang S, Zhao Q, Zhang H, Mo Z. (2004). Determination of degree of crystallinity of nylon 1212 by wide-angle X-ray diffraction. Ch J Poly Sci, 22:491–496.
   Web of Science ®Google Scholar
• Widjaja E, Li CZ, Chew W, Garland M. (2003). Band Target Entropy Minimization. A general and robust algorithm for pure component spectral recovery: application to complex randomized mixtures of six components. Anal Chem, 75:4499–4507.
   PubMed Web of Science ®Google Scholar
• Breitenbach J, Schrof W, Neumann J. (1999). Confocal Raman spectroscopy: analytical approach to solid dispersions and mapping of drugs. Pharm Res, 16:1109–1113.
   PubMed Web of Science ®Google Scholar
• Widjaja E, Seah RK. (2008). Application of Raman microscopy and band-target entropy minimization to identify minor components in model pharmaceutical tablets. J Pharm Biomed Anal, 46:274–281.
   PubMed Web of Science ®Google Scholar
• Jantratid E, Janssen N, Reppas C, Dressman JB. (2008). Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res, 25:1663–1676.
   PubMed Web of Science ®Google Scholar
• Mididoddi PK, Repka MA. (2007). Characterization of hot-melt extruded drug delivery systems for onychomycosis. Eur J Pharm Biopharm, 66:95–105.
   PubMed Web of Science ®Google Scholar
• He H, Yang R, Tang X. (2010). In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion. Drug Dev Ind Pharm, 36:681–687.
   PubMed Web of Science ®Google Scholar